Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Titan Shares Rise After FDA Panel Backs Opioid Implant
Titan Shares Rise After FDA Panel Backs Opioid Implant
Titan Shares Rise After FDA Panel Backs Opioid Implant
Submitted by
admin
on March 23, 2013 - 8:49am
Source:
Bloomberg
News Tags:
Titan Pharmaceuticals
Probuphine
opioid addiction
Headline:
Titan Shares Rise After FDA Panel Backs Opioid Implant
Do Not Allow Advertisers to Use My Personal information
